Drugs Made In America Acquisition logo

Drugs Made In America Acquisition

Private Equity Group

US

Drugs Made In America Acquisition is a blank check company focused on identifying and acquiring businesses in the pharmaceutical industry. The company aims to enhance domestic manufacturing capabilities and mitigate supply chain risks, ensuring a stable supply of critical medications. It is publicly traded on Nasdaq under the symbol DMAAU.

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →